Net Income

As the healthcare industry bleeds talent, PruittHealth's fifth consecutive 'Great Place to Work' award reveals its culture-first strategy for retention and growth.

A novel device that treats hypertension from outside the artery shows early promise, challenging market leaders and offering new hope for millions.

Soaring costs and long waits at home are driving thousands of Europeans to Albania for dental implants, where clinics offer top-tier care for less.

As GAAD marks 15 years, Level Access democratizes training to bridge the digital divide, proving accessibility is no longer just a cause, but a revenue driver.

A new prop firm says its capital-backed framework will ensure sustainable trader payouts, aiming to bring a new standard of transparency to the industry.

The Nexus Forum launches to connect China's booming biotech scene with global pharma, capitalizing on a major shift in worldwide drug discovery and deal-making.

NFL legend Brett Favre reports gains from an experimental Parkinson's drug, but what does the science say about this potential breakthrough treatment?

With the hire of veteran Sarah Schmitz, Balefire Wealth signals a major strategic expansion into the complex world of corporate retirement consulting.

Former Trump official Peter O'Rourke joins AI defense firm Quantum Cyber, a move signaling a major push for government contracts in autonomous warfare.

An ambitious challenge aims to turn Amazon biodiversity into sustainable businesses, betting that entrepreneurship is the key to the rainforest's survival.

The biopharma posts record Q1 revenue and profit, driven by its flagship DefenCath and a key acquisition, while a promising pipeline signals future growth.

Industry titans from Manchester United to DraftKings will convene to map out the future of streaming, gaming, and sports in a shifting regulatory landscape.

Dr. Amie Hornaman's bestseller, The Thyroid Fix, confronts medical gaslighting, empowering women to look beyond 'normal' lab results for answers.

SoundThinking hires Mark43 veteran David Jochim to lead its TechnoLogic division, signaling a strategic push for operational excellence and delivery.

Early human trial data for a new drug, UDP-003, suggests it can safely remove toxic cholesterol, a key step toward reversing arterial plaque buildup.

Brookfield Wealth Solutions plans to merge with its parent company, posting stable operating earnings despite a net loss driven by market fluctuations.

Fresh off its IPO, Agomab Therapeutics is presenting key data for its new IPF drug, AGMB-447, while courting investors on a multi-conference tour.

Natrol launches Ultra Sleep and Energy, partnering with Calm and Michelle Monaghan in a bold move to connect restorative rest with daytime vitality.

Drowning is a leading, often silent, cause of death for kids. As rates rise, the Red Cross is launching new Spanish-language resources to bridge a deadly gap.

A new industry report reveals a major shift: patient trust and clinical skill, not size, are the new keys to success for modern dental practices.